“…For infants requiring early surgical intervention, studies have shown that positive genetic testing results have been associated with post-operative complications and survival and can impact care and resource utilization [ 16 , 41 , 42 , 43 , 44 , 45 ]. Cohort studies have demonstrated that genetic testing of newborns with CHD yields an overall diagnostic rate of ~30% with genome-wide analysis [ 46 , 47 , 48 , 49 , 50 ]. The testing yield is slightly higher in cases of CHD with extra-cardiac anomalies, but results are still robust when the CHD is isolated [ 51 , 52 ].…”